Ocugen, Inc. (OCGN) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to Oxygen's fourth quarter and full year 2025 financial results and business update. All participant lines are currently in listen-only mode. Following the speaker's commentary, there will be a question and answer session. I will now turn the call over to Tiffany Hamilton, Oxygen's Head of Corporate Communications. You may begin. Thank you, Operator, and good morning, everyone. Joining me on today's call and webcast is Dr. Shankar Musuneri, OccuGen's chairman, CEO, and co-founder, who will provide a business update and an overview of our clinical and operational progress. Rita Johnson-Green, our chief financial officer, is also on the call to provide a financial update for the quarter and full year ended December 31st, 2025. Dr. Huma Kumar, chief medical officer, will be available to answer questions following the presentations. This morning, we issued a press release detailing associated business and operational highlights for the fourth quarter and full year 2025. We encourage listeners to review the press release, which is available on our website at Occugen.com. A replay of this call, along with the accompanying slide presentation, will be available on the investor section of the Occugen website. Before we begin, please note that certain statements made during today's discussion may be forward-looking in nature. including those related to our clinical development pipeline, regulatory timelines, commercialization strategy, and financial information in our anticipated cash runway. These statements reflect management's current expectations and are inherently subject to risks, uncertainties, and assumptions that may cause actual outcomes to differ materially from those expressed or implied. We encourage you to review our filings with Securiti...